Current Trends and Future Challenges in Rheumatology

A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Personalized Therapy and Drug Delivery".

Deadline for manuscript submissions: 20 September 2024 | Viewed by 244

Special Issue Editor


E-Mail Website
Guest Editor
Rheumatology Department, Usl Tuscany Center, San Giovanni di Dio Hospital, Via di Torre Galli 3, 50143 Florence, Italy
Interests: connective disease; vasculitis; rheumatoid arthritis; spondyloarhtitis; ultrasound; rare disease
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

We are pleased to announce the launch of a new Special Issue, “Current Trends and Future Challenges in Rheumatology [JPM]”.

There is a need for personalized and modern strategies in prediction, early diagnosis, and tailored treatment in arthritis, vasculitis, connective tissue, and rare diseases.

This Special Issue aims to elucidate the most recent innovations in prevention, early diagnosis, and treatment in rheumatology.

There are still many underexplored aspects of the role of constitutive (genes, microbiota, biopsy patterns, and gender) and external (infections and lifestyle) factors in rheumatic diseases. Modern medicine is oriented to develop innovative integrated systems (algorithms and machine learning) and new biomarkers to predict different phenotypes and severity. The COVID-19 pandemic changed many views, introducing “smart medicine” with the implementation of non-face-to-face visits with telemedicine and innovative uses of imaging (ultrasound, magnetic resonance, HRCT, and PET), which had important consequences for the knowledge of emerging underestimated rare diseases.

This Special Issue offers to explore these fascinating aspects:

  1. Identification of predictive and pathogenetic factors, in particular in understated and rare diseases;
  2. Innovative diagnostic tools in histology, laboratory, and imaging biomarkers;
  3. Algorithms, artificial intelligence, and telemedicine;
  4. Tailored emerging new drugs.

We are soliciting original articles, meta-analyses, reviews, and case series related to future challenges in rheumatology.

Dr. Francesca Bandinelli
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • rheumatology
  • connective disease
  • vasculitis
  • rheumatoid arthritis
  • telemedicine
  • imaging

Published Papers

This special issue is now open for submission.
Back to TopTop